We therefore derived a gene expression‐based equation that uses a previously identified “PCNA metagene” to predict fractional proliferation, using the SCANB breast cancer transcriptomic study for calibration (Figure 3B).12, 22, 23, 24. Here, PCNA is linked to breast cancer.